Tigemonam

Tigemonam
Names
Other namesTigemen
IUPAC name
  • 2-[[1-(2-Amino-1,3-thiazol-4-yl)- 2-[[(3S)-2,2-dimethyl-4-oxo-1- sulfooxyazetidin-3-yl]amino]-2- oxoethylidene]amino]oxyacetic acid
Clinical data
WHO AWaReUnlinkedWikibase error: ⧼unlinkedwikibase-error-statements-entity-not-set⧽
Chemical and physical data
FormulaC12H15N5O9S2
Molar mass437.40 g·mol−1
3D model (JSmol)
SMILES
  • CC1([C@@H](C(=O)N1OS(=O)(=O)O)NC(=O)/C(=N\OCC(=O)O)/C2=CSC(=N2)N)C
InChI
  • InChI=1S/C12H15N5O9S2/c1-12(2)8(10(21)17(12)26-28(22,23)24)15-9(20)7(16-25-3-6(18)19)5-4-27-11(13)14-5/h4,8H,3H2,1-2H3,(H2,13,14)(H,15,20)(H,18,19)(H,22,23,24)/b16-7-/t8-/m1/s1 ☒N
  • Key:VAMSVIZLXJOLHZ-QWFSEIHXSA-N ☒N

Tigemonam is a monobactam antibiotic.[1][2]

References

  1. ↑ Page, Malcolm G. P. (2011). "3. Beta-Lactam antibiotics". In Dougherty, Thomas J.; Pucci, Michael J. (eds.). Antibiotic Discovery and Development. New York: Springer Science & Business Media. pp. 104–105. ISBN 978-1-4614-1399-8.
  2. ↑ Chin NX, Neu HC (January 1988). "Tigemonam, an oral monobactam". Antimicrob. Agents Chemother. 32 (1): 84–91. doi:10.1128/aac.32.1.84. PMC 172104. PMID 3279906.
Identifiers:


This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.